Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Francisella tularensis antigens encompass a variety of molecular components, including lipopolysaccharides (LPS) and outer membrane proteins such as FopA, Tul4, and IglC (Sjöstedt, 2003). These molecules are essential for the bacterium's virulence and survival within host macrophages, facilitating the evasion of host defenses (Gunn & Ernst, 2007). These antigens are the primary focus for the development of vaccines and diagnostic assays aimed at Tularemia, a highly infectious disease caused by this Gram-negative coccobacillus (Sjöstedt, 2006). The LPS of F. tularensis is unique in its structure, contributing to the pathogen's ability to evade detection by the host's Toll-like receptors, thereby delaying the innate immune response (Hajjar et al., 2006). Therapeutic strategies targeting these antigens primarily involve the development of live-attenuated or subunit vaccines designed to stimulate robust T-cell mediated immunity (Conlan, 2011). This cellular response is crucial for clearing intracellular infections where antibodies alone may be insufficient. Given its status as a Tier 1 select agent and potential biothreat, understanding and targeting these antigens is a priority for both clinical medicine and biodefense research (Dennis et al., 2001).
Induction of protective humoral and cellular immune responses through activation of B-cells and T-cells (Conlan, 2011).
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Francisella tularensis antigens (F. tularensis antigens).